Schedule 13G ownership disclosure
Fate Therapeutics Inc
Security class unavailable · CUSIP: 31189P102
Event date: 2019-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,229,154
- Percent of class
- 5.5900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001040188-20-000081
- Form type
- SC 13G
- Filer
- FATE THERAPEUTICS INC
- CIK
- CIK 1434316
- Filed
- Jan 31, 2020
- Reporting period
- Dec 31, 2019
- Description
- Schedule 13G beneficial ownership